CoChat
Sign Up
Cited by 114

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Regional Distribution of Amyloid-Bri Deposition and Its Association with Neurofibrillary Degeneration in Familial British Dementia

Holton, Janice L., Ghiso, Jorge, Lashley, Tammaryn, Rostagno, Agueda, Guerin, Christopher J., Gibb, Graham, Houlden, Henry, Ayling, Hilary, Martinian, Lillian, Anderton, Brian H., Wood, Nicholas W., Vidal, Ruben, Plant, Gordon, Frangione, Blas, Revesz, Tamas·2001·The American Journal of Pathology
DOI 10.1016/s0002-9440(10)63993-4
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)63993-4

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 39

  1. Worster-Drought, 1933, Familial presenile dementia with spastic paralysis, J Neurol Psychopathol, 14, 27, 10.1136/jnnp.s1-14.53.27 · DOI
  2. Plant, 1990, Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation, Brain, 113, 721, 10.1093/brain/113.3.721 · DOI
  3. Mead, 2000, Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings, Brain, 123, 975, 10.1093/brain/123.5.975 · DOI
  4. Worster-Drought, 1940, A form of familial presenile dementia with spastic paralysis (including the pathological examination of a case), Brain, 63, 237, 10.1093/brain/63.3.237 · DOI
  5. Revesz, 1999, Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation, Acta Neuropathol (Berl), 97, 170, 10.1007/s004010050970 · DOI
  6. Vidal, 1999, A stop-codon mutation in the BRI gene associated with familial British dementia, Nature, 399, 776, 10.1038/21637 · DOI · Paper page
  7. Mirra, 1991, The consortium to establish a registry for Alzheimer's disease (CERAD). 2. Standardization of the neuropathologic assessment of Alzheimer's disease, Neurology, 41, 479, 10.1212/WNL.41.4.479 · DOI · Paper page
  8. Brion, 1993, Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease, J Neurochem, 60, 1372, 10.1111/j.1471-4159.1993.tb03298.x · DOI
  9. Hanger, 1991, Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated, Biochem J, 275, 99, 10.1042/bj2750099 · DOI
  10. Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227, 680, 10.1038/227680a0 · DOI · Paper page
  11. Yamaguchi, 1987, Alzheimer's neurofibrillary tangles are penetrated by astroglial processes and appear eosinophilic in their final stages, Acta Neuropathol (Berl), 72, 214, 10.1007/BF00691092 · DOI
  12. Bondareff, 1994, Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease, J Neuropathol Exp Neurol, 53, 158, 10.1097/00005072-199403000-00007 · DOI
  13. Bjorklund, 1985, Image analysis of GFA-positive astrocytes from adolescence to senescence, Exp Brain Res, 58, 163, 10.1007/BF00238964 · DOI
  14. Verga, 1989, Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques, Neurosci Lett, 105, 294, 10.1016/0304-3940(89)90636-8 · DOI
  15. Giaccone, 1992, Prion protein preamyloid and amyloid deposits in Gerstmann-Straussler-Scheinker disease, Indiana kindred, Proc Natl Acad Sci USA, 89, 9349, 10.1073/pnas.89.19.9349 · DOI
  16. Griffiths, 1982, Congophilic angiopathy of the brain: a clinical and pathological report on two siblings, J Neurol Neurosurg Psychiatry, 45, 396, 10.1136/jnnp.45.5.396 · DOI
  17. Love, 1982, Familial cerebellar ataxia with cerebrovascular amyloid, J Neurol Neurosurg Psychiatry, 45, 271, 10.1136/jnnp.45.3.271 · DOI
  18. Kalus, 1989, The presubicular region in Alzheimer's disease: topography of amyloid deposits and neurofibrillary changes, Brain Res, 494, 198, 10.1016/0006-8993(89)90164-9 · DOI
  19. Ogomori, 1989, Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease, Am J Pathol, 134, 243
  20. Goedert, 1993, The abnormal phosphorylation of tau-protein at ser-202 in Alzheimer disease recapitulates phosphorylation during development, Proc Natl Acad Sci USA, 90, 5066, 10.1073/pnas.90.11.5066 · DOI · Paper page
  21. Su, 1994, Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites, Neuroreport, 5, 2358, 10.1097/00001756-199411000-00037 · DOI
  22. Schmidt, 1994, An extensive network of PHF-τ-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease, FEBS Lett, 344, 69, 10.1016/0014-5793(94)00259-2 · DOI
  23. Yamaguchi, 1991, Secondary deposition of beta amyloid within extracellular neurofibrillary tangles in Alzheimer-type dementia, Am J Pathol, 138, 699
  24. ZhengFischhofer, 1998, Sequential phosphorylation of Tau by glycogen synthase kinase-3 beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation, Eur J Biochem, 252, 542, 10.1046/j.1432-1327.1998.2520542.x · DOI
  25. el Hachimi, 1991, Relationship between non-fibrillary amyloid precursors and cell processes in the cortical neuropil of Alzheimer patients, Neurosci Lett, 129, 119, 10.1016/0304-3940(91)90734-B · DOI
  26. Pike, 1995, Early association of reactive astrocytes with senile plaques in Alzheimer's disease, Exp Neurol, 132, 172, 10.1016/0014-4886(95)90022-5 · DOI · Paper page
  27. Selkoe, 1999, Translating cell biology into therapeutic advances in Alzheimer's disease, Nature, 399, A23, 10.1038/399a023 · DOI · Paper page
  28. Weller, 1998, Cerebral amyloid angiopathy—amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease, Am J Pathol, 153, 725, 10.1016/S0002-9440(10)65616-7 · DOI · Paper page
  29. Kim, 1999, Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia, Nat Neurosci, 2, 984, 10.1038/14783 · DOI · Paper page
  30. Day, 1993, Region specific expression of furin mRNA in the rat brain, Neurosci Lett, 149, 27, 10.1016/0304-3940(93)90339-M · DOI
  31. Probst, 1991, Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques, Acta Neuropathol (Berl), 83, 21, 10.1007/BF00294426 · DOI
  32. Mann, 1992, Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease, Acta Neuropathol (Berl), 83, 415, 10.1007/BF00713534 · DOI
  33. Calhoun, 1999, Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid, Proc Natl Acad Sci USA, 96, 14088, 10.1073/pnas.96.24.14088 · DOI · Paper page
  34. Ghiso, 1997, Alzheimer's soluble amyloid beta is a normal component of human urine, FEBS Lett, 408, 105, 10.1016/S0014-5793(97)00400-6 · DOI
  35. Spillantini, 1998, Tau protein pathology in neurodegenerative diseases, Trends Neurosci, 21, 428, 10.1016/S0166-2236(98)01337-X · DOI · Paper page
  36. Crook, 1998, A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1, Nat Med, 4, 452, 10.1038/nm0498-452 · DOI
  37. Houlden, 2000, Variant Alzheimer's disease with spastic paraparesis and ‘cotton wool’ plaques is caused by PS-1 mutations which lead to exceptionally high Aβ concentrations, Ann Neurol, 68, 806, 10.1002/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO;2-F · DOI
  38. Gray, 1985, Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy, Ann Neurol, 18, 54, 10.1002/ana.410180110 · DOI
  39. Vinters, 1990, Immunohistochemical study of cerebral amyloid angiopathy. III. Widespread Alzheimer A4 peptide in cerebral microvessel walls colocalizes with gamma trace in patients with leukoencephalopathy, Ann Neurol, 28, 34, 10.1002/ana.410280108 · DOI

Cited by

Sorted by citations

Metadata

Authors
Holton, J. L., Ghiso, J., Lashley, T., Rostagno, A., Guerin, C. J., Gibb, G., Houlden, H., Ayling, H., Martinian, L., Anderton, B. H., Wood, N. W., Vidal, R., Plant, G., Frangione, B., & Revesz, T.
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2001-02
Volume
158
Issue
2
Pages
515-526
ISSN
0002-9440
DOI
10.1016/s0002-9440(10)63993-4
Cited by
114
References
5
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review